- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Presentation 1: Oncology Practice in the Era of PCMHs and ACOs: Square Pegs or Round Holes?
Dr Peter Bach says professionals are looking at opportunities for new payment models and care redesign, but there are also threats that might surface. Each type of insurance payment model has different levels of risk factors. New payment models, such as the UHC pathways program and CMMI demo, have limited risk.
Dr Peter Bach says professionals are looking at opportunities for new payment models and care redesign, but there are also threats that might surface. Each type of insurance payment model has different levels of risk factors. New payment models, such as the UHC pathways program and CMMI demo, have limited risk.
In regard to the future of payment, Dr Bach suggests that models such as the patient-centered medical home and accountable care organization, which boast shared savings, are likely to be useful. For oncology, the general “thrust” is to find savings outside drug expenditures, including reduced use of testing and avoiding hospitalization costs. “The general trend is to move risk, and it’s to move it where the discretionary decisions are made,” says Dr Bach. “It’s not a question of if, but when.”
Dr Bach also elaborates on why the site of care matters. Programs such as 340B, which offers discount drugs to hospitals that treat large populations of poor patients, impact costs. Finally, Bach suggests how this shift in site of care could benefit oncology patients.
Obesity at Cancer Diagnosis Linked to Worse Survival Outcomes in Pediatric Patients
January 13th 2025Pediatric patients considered obese at cancer diagnosis are linked to significantly worse survival outcomes, especially those with acute lymphoblastic leukemia and central nervous system tumors.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization
January 8th 2025High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.
Read More
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
